Gaxos.ai Inc. (NASDAQ: GXAI) has outlined its post-divestiture operating strategy following the sale of its gaming assets, stating it will focus on expanding its AI applications business through Gaxos Labs and the personalized health and wellness offerings of its majority-owned subsidiary RNK Health. The company announced that the strategic realignment follows significant first-quarter 2026 revenue growth to approximately $1.81 million, driven primarily by RNK Health and subscriptions to Gaxos Labs applications.
The company said its priorities include scaling revenue-generating platforms, improving customer acquisition efficiency, advancing commercially focused AI products, and maintaining disciplined capital allocation. Gaxos also noted it will continue to hold its 19.99% ownership interest in America First Defense.AI while providing separate reporting on that investment, and plans to enhance investor communications with additional operating performance metrics as its businesses continue to grow. The full press release is available at https://ibn.fm/G9Ld7.
Gaxos.AI is a technology company focused on reshaping how people interact with artificial intelligence across everyday life and high-impact industries. The company builds a portfolio of AI-powered solutions designed to make advanced technology more practical, accessible, and transformative. Its growing portfolio spans defense, health and wellness, entertainment, and productivity, bringing intelligent tools to markets where innovation can drive meaningful real-world outcomes.
The strategic shift comes as Gaxos seeks to capitalize on the growing demand for AI-driven health and wellness applications. RNK Health, a majority-owned subsidiary, is expected to play a key role in the company's future growth, leveraging personalized health offerings. Meanwhile, Gaxos Labs will continue to develop and commercialize AI applications across various sectors.
Investors can find the latest news and updates on GXAI in the company’s newsroom at https://ibn.fm/GXAI.
